A study evaluating venetoclax in Multiple Myeloma subjects, who are receiving bortezomib and dexamethasone as standard therapy

Update Il y a 4 ans
Reference: EUCTR2015-004411-20

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Progression Free Survival


Inclusion criteria

  • Relapsed or Refractory Multiple Myeloma